Seasoned global development executive with a track record mobilizing philanthropic and catalytic capital for health, resilience and climate initiatives across emerging markets. Rajiv Shah is a physician-turned-executive who has led major philanthropic institutions and government development programs, coordinating large-scale grant portfolios, public–private partnerships and data-driven interventions that attract private investors and institutional donors. Focused on scaling impact through blended finance, policy engagement and measurement frameworks, his profile is relevant to investors tracking philanthropic capital flows, impact funds and socially aligned corporate partnerships. Known for convening multisector coalitions, advising on program design and directing operational teams to deploy capital for measurable outcomes.
Seasoned global development executive with a track record mobilizing philanthropic and catalytic capital for health, resilience and climate initiatives across emerging markets. Rajiv Shah is a physician-turned-executive who has led major philanthropic institutions and government development programs, coordinating large-scale grant portfolios, public–private partnerships and data-driven interventions that attract private investors and institutional donors. Focused on scaling impact through blended finance, policy engagement and measurement frameworks, his profile is relevant to investors tracking philanthropic capital flows, impact funds and socially aligned corporate partnerships. Known for convening multisector coalitions, advising on program design and directing operational teams to deploy capital for measurable outcomes.
Prioritizes catalytic, patient capital that blends philanthropic grants, concessional finance and private investment to scale health, climate and resilience solutions in emerging markets. Uses policy engagement, multisector partnerships and rigorous measurement to de-risk early-stage models and attract commercial follow‑on funding. Focuses on outcome-driven underwriting, portfolio diversification by geography and instrument, and staged capital deployment tied to metrics. Emphasizes convening power and operational support to translate grants into investable, scalable enterprises.
Prioritizes catalytic, patient capital that blends philanthropic grants, concessional finance and private investment to scale health, climate and resilience solutions in emerging markets. Uses policy engagement, multisector partnerships and rigorous measurement to de-risk early-stage models and attract commercial follow‑on funding. Focuses on outcome-driven underwriting, portfolio diversification by geography and instrument, and staged capital deployment tied to metrics. Emphasizes convening power and operational support to translate grants into investable, scalable enterprises.
| Trades 8812 | Longs Won 5906/8812 67% | Profit Factor 5.58 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $841,609.96 |
| Average Win $156,203.44 | Best Trade (Aug 28) $30.17M | Sharpe Ratio -12.81 |
| Average Loss -$56,872.47 | Worst Trade (Jun 30) -$36.12M | Z-Score 22.06 (100%) |
| Commissions $0 | Avg. Trade Length 11m 1w | Expectancy $85,935.78 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 43,478 | 39,130 | 34,783 | 30,435 | 26,087 | 21,739 | 17,391 | 13,043 | 8,696 | 4,348 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 318,568 | $75.71M | $98.41M | - | $22.7M | 29.99% | -7.354% |
AB AllianceBernstein Holding L.P. | 35,110 | $1.24M | $1.29M | - | $54,069.6 | 4.37% | +0.109% |
ABBV AbbVie Inc. | 37,047 | $8.32M | $9.3M | - | $973,553.3 | 11.7% | -2.513% |
ABNB Airbnb, Inc. | 2,059 | $275,850.83 | $311,979.68 | - | $36,128.85 | 13.1% | -0.368% |
ABT Abbott Laboratories | 11,849 | $1.54M | $1.25M | - | -$286,821.57 | -18.63% | +0.085% |
ABTC Gryphon Digital Mining, Inc | 800.98 | $11,051.19 | $4,421.44 | - | -$6,629.75 | -59.99% | -6.441% |
ACMR Acm Research Inc. | 2,331 | $295,781 | $182,913.57 | - | -$112,867.43 | -38.16% | -0.229% |
ACP abrdn Income Credit Strategies Fund | 15,427 | $102,126.8 | $78,060.62 | - | -$24,066.18 | -23.56% | -0.197% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 3,963 | $271,346.3 | $298,215.75 | - | $26,869.45 | 9.9% | -0.172% |
ACYN FT Vest Laddered Autocallable Barrier & Income ETF | 58,821 | $1.22M | $1.22M | - | -$5,882.51 | -0.48% | -0.097% |
ADBE Adobe Inc. | 1,780 | $801,284.09 | $445,729.8 | - | -$355,554.29 | -44.37% | +1.013% |
ADI Analog Devices, Inc. | 12,728 | $3.43M | $4.68M | - | $1.25M | 36.49% | +0.202% |
ADM Archer-Daniels-Midland Co | 7,692 | $410,259.94 | $609,744.84 | - | $199,484.9 | 48.62% | -1.662% |
ADP Automatic Data Processing Inc. | 3,158 | $811,893.45 | $841,480.65 | - | $29,587.2 | 3.64% | +0.982% |
ADSK Autodesk, Inc. | 3,034 | $856,439.64 | $710,562.8 | - | -$145,876.84 | -17.03% | -0.328% |
ADX Adams Diversified Equity Fund, Inc. | 19,313 | $421,010.33 | $492,867.76 | - | $71,857.43 | 17.07% | +1.27% |
AEM Agnico Eagle Mines Limited | 2,658 | $445,172.38 | $386,127.66 | - | -$59,044.72 | -13.26% | -3.635% |
AEP American Electric Power Company, Inc. | 16,620 | $1.87M | $2.12M | - | $254,289.78 | 13.59% | +0.055% |
AFL Aflac Inc. | 10,559 | $1.17M | $1.35M | - | $171,266.76 | 14.58% | +0.094% |
AGG iShares Core U.S. Aggregate Bond ETF | 109,462 | $10.92M | $10.66M | - | -$257,007.58 | -2.35% | -0.256% |